Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1210828-44-6

Post Buying Request

1210828-44-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1210828-44-6 Usage

General Description

7-Quinolinol, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy- is a complex chemical compound with a molecular formula C21H16FN3O3. It is comprised of a quinolinol core with a 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy- substituent, making it a derivative of both quinolinol and indole. This chemical is utilized in various research and industrial applications, including as a building block in the synthesis of pharmaceutical compounds and as a fluorescence label for biochemical assays. Additionally, it exhibits potential pharmaceutical properties, particularly in the areas of antiviral and antiparasitic activity. However, further research and testing are required to fully understand and harness the potential of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1210828-44-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,0,8,2 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1210828-44:
(9*1)+(8*2)+(7*1)+(6*0)+(5*8)+(4*2)+(3*8)+(2*4)+(1*4)=116
116 % 10 = 6
So 1210828-44-6 is a valid CAS Registry Number.

1210828-44-6Relevant articles and documents

Angiogenesis inhibitor as well as preparation method and application thereof

-

, (2021/02/13)

The invention belongs to the technical field of medicines, and discloses a compound shown as a formula I or pharmaceutically acceptable salt, prodrug, metabolite, isotope derivative and solvate thereof. The compound provided by the invention is a cyclobutyl-containing compound used as a tyrosine kinase inhibitor, and can be used for treating tyrosine kinase, especially tumor diseases related to VEGFR. Due to the existence of the cyclobutyl group, the rigidity of a branched chain molecule can be improved, the directivity of the molecule is improved, the compound can be better combined with a target easily, the dosage of a drug can be reduced, and the side effect of the drug is reduced. The invention also provides a preparation method of the compound and application of the compound in treatment of tumor diseases caused by abnormal activity of tyrosine kinase such as VEGFR.

Method for preparing anlotinib hydrochloride

-

Paragraph 0050-0052, (2019/05/28)

The invention discloses a method for preparing anlotinib hydrochloride. The method has the advantages that 7-benzyloxy-4-chlorine-6-methoxyquinoline compounds 1 and 1-(2-fluorine-3-hydroxyl-6-nitrophenyl) propyl-2-ketone compounds 2 are used as starting m

Compounds As Kinase Inhibitors

-

Page/Page column 14, (2010/03/31)

The present invention relates to compounds of Formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with angiogenesis, such as cancers associated with protein tyrosine kinases, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1210828-44-6